Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer A Systematic Review and Meta-Analysis
Publication in refereed journal


Times Cited
Web of Science42WOS source URL (as at 08/08/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractTumor tissues are often absent or insufficient for testing epidermal growth factor receptor (EGFR) mutations to guide EGFR tyrosine kinase inhibitors (TKIs) treatment of patients with nonsmall cell lung cancer (NSCLC).
All Author(s) ListMao C, Yuan JQ, Yang ZY, Fu XH, Wu XY, Tang JL
Journal nameMedicine
Year2015
Month5
Day1
Volume Number94
Issue Number21
PublisherLIPPINCOTT WILLIAMS & WILKINS
ISSN0025-7974
eISSN1536-5964
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesGeneral & Internal Medicine; Medicine, General & Internal

Last updated on 2020-09-08 at 06:33